Effect of green coffee extract supplementation in patients with type 2 diabetes

Not Applicable

Not yet recruiting

• Conditions: Diabetes mellitus due to underlying condition; Type 2 diabetes.

• Registration Number: IRCT20090203001640N18
• Lead Sponsor: Vice Chancellor for Research of Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 July 2020

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

Agreement to participate in the study and completing informed consent form
Subjects aged 35-70 years old
Body mass index between 25-35 kg/m2
Fasting blood glucose = 126 mg/dl or 2-h plasma glucose =200 mg/dl or treatment with anti-hyperglycemic medications

Exclusion Criteria

Following any specific diet in past three months
Pregnant and lactating women
Insulin treatment

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fasting blood glucose. Timepoint: At the beginning and end of the study. Method of measurement: Enzymatic /kit.;Plasma insulin. Timepoint: At the beginning and end of the study. Method of measurement: ELISA.;Plasma triglyceride. Timepoint: At the beginning and end of the study. Method of measurement: Enzymatic /kit.;Malondialdehyde. Timepoint: At the beginning and end of the study. Method of measurement: Colorimetric.;Carboxymethyl lysine. Timepoint: At the beginning and end of the study. Method of measurement: ELISA.;High-sensitivity C-reactive protein. Timepoint: At the beginning and end of the study. Method of measurement: ELISA.

Secondary Outcome Measures

Name	Time	Method
Body mass index. Timepoint: At the beginning and end of the study. Method of measurement: Weight in kilograms divided by height in meters squared.;Systolic blood pressure. Timepoint: At the beginning and end of the study. Method of measurement: Mercury sphygmomanometer.;Diastolic blood pressure. Timepoint: At the beginning and end of the study. Method of measurement: Mercury sphygmomanometer.